Cargando…
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
The first SARS-CoV-2 variant of concern (VOC) to be designated was lineage B.1.1.7, later labelled by the World Health Organization as Alpha. Originating in early autumn but discovered in December 2020, it spread rapidly and caused large waves of infections worldwide. The Alpha variant is notable fo...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752794/ https://www.ncbi.nlm.nih.gov/pubmed/36533153 http://dx.doi.org/10.1093/ve/veac080 |
_version_ | 1784850815158059008 |
---|---|
author | Hill, Verity Du Plessis, Louis Peacock, Thomas P Aggarwal, Dinesh Colquhoun, Rachel Carabelli, Alesandro M Ellaby, Nicholas Gallagher, Eileen Groves, Natalie Jackson, Ben McCrone, J T O’Toole, Áine Price, Anna Sanderson, Theo Scher, Emily Southgate, Joel Volz, Erik Barclay, Wendy S Barrett, Jeffrey C Chand, Meera Connor, Thomas Goodfellow, Ian Gupta, Ravindra K Harrison, Ewan M Loman, Nicholas Myers, Richard Robertson, David L Pybus, Oliver G Rambaut, Andrew |
author_facet | Hill, Verity Du Plessis, Louis Peacock, Thomas P Aggarwal, Dinesh Colquhoun, Rachel Carabelli, Alesandro M Ellaby, Nicholas Gallagher, Eileen Groves, Natalie Jackson, Ben McCrone, J T O’Toole, Áine Price, Anna Sanderson, Theo Scher, Emily Southgate, Joel Volz, Erik Barclay, Wendy S Barrett, Jeffrey C Chand, Meera Connor, Thomas Goodfellow, Ian Gupta, Ravindra K Harrison, Ewan M Loman, Nicholas Myers, Richard Robertson, David L Pybus, Oliver G Rambaut, Andrew |
author_sort | Hill, Verity |
collection | PubMed |
description | The first SARS-CoV-2 variant of concern (VOC) to be designated was lineage B.1.1.7, later labelled by the World Health Organization as Alpha. Originating in early autumn but discovered in December 2020, it spread rapidly and caused large waves of infections worldwide. The Alpha variant is notable for being defined by a long ancestral phylogenetic branch with an increased evolutionary rate, along which only two sequences have been sampled. Alpha genomes comprise a well-supported monophyletic clade within which the evolutionary rate is typical of SARS-CoV-2. The Alpha epidemic continued to grow despite the continued restrictions on social mixing across the UK and the imposition of new restrictions, in particular, the English national lockdown in November 2020. While these interventions succeeded in reducing the absolute number of cases, the impact of these non-pharmaceutical interventions was predominantly to drive the decline of the SARS-CoV-2 lineages that preceded Alpha. We investigate the only two sampled sequences that fall on the branch ancestral to Alpha. We find that one is likely to be a true intermediate sequence, providing information about the order of mutational events that led to Alpha. We explore alternate hypotheses that can explain how Alpha acquired a large number of mutations yet remained largely unobserved in a region of high genomic surveillance: an under-sampled geographical location, a non-human animal population, or a chronically infected individual. We conclude that the latter provides the best explanation of the observed behaviour and dynamics of the variant, although the individual need not be immunocompromised, as persistently infected immunocompetent hosts also display a higher within-host rate of evolution. Finally, we compare the ancestral branches and mutation profiles of other VOCs and find that Delta appears to be an outlier both in terms of the genomic locations of its defining mutations and a lack of the rapid evolutionary rate on its ancestral branch. As new variants, such as Omicron, continue to evolve (potentially through similar mechanisms), it remains important to investigate the origins of other variants to identify ways to potentially disrupt their evolution and emergence. |
format | Online Article Text |
id | pubmed-9752794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-97527942022-12-16 The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK Hill, Verity Du Plessis, Louis Peacock, Thomas P Aggarwal, Dinesh Colquhoun, Rachel Carabelli, Alesandro M Ellaby, Nicholas Gallagher, Eileen Groves, Natalie Jackson, Ben McCrone, J T O’Toole, Áine Price, Anna Sanderson, Theo Scher, Emily Southgate, Joel Volz, Erik Barclay, Wendy S Barrett, Jeffrey C Chand, Meera Connor, Thomas Goodfellow, Ian Gupta, Ravindra K Harrison, Ewan M Loman, Nicholas Myers, Richard Robertson, David L Pybus, Oliver G Rambaut, Andrew Virus Evol Research Article The first SARS-CoV-2 variant of concern (VOC) to be designated was lineage B.1.1.7, later labelled by the World Health Organization as Alpha. Originating in early autumn but discovered in December 2020, it spread rapidly and caused large waves of infections worldwide. The Alpha variant is notable for being defined by a long ancestral phylogenetic branch with an increased evolutionary rate, along which only two sequences have been sampled. Alpha genomes comprise a well-supported monophyletic clade within which the evolutionary rate is typical of SARS-CoV-2. The Alpha epidemic continued to grow despite the continued restrictions on social mixing across the UK and the imposition of new restrictions, in particular, the English national lockdown in November 2020. While these interventions succeeded in reducing the absolute number of cases, the impact of these non-pharmaceutical interventions was predominantly to drive the decline of the SARS-CoV-2 lineages that preceded Alpha. We investigate the only two sampled sequences that fall on the branch ancestral to Alpha. We find that one is likely to be a true intermediate sequence, providing information about the order of mutational events that led to Alpha. We explore alternate hypotheses that can explain how Alpha acquired a large number of mutations yet remained largely unobserved in a region of high genomic surveillance: an under-sampled geographical location, a non-human animal population, or a chronically infected individual. We conclude that the latter provides the best explanation of the observed behaviour and dynamics of the variant, although the individual need not be immunocompromised, as persistently infected immunocompetent hosts also display a higher within-host rate of evolution. Finally, we compare the ancestral branches and mutation profiles of other VOCs and find that Delta appears to be an outlier both in terms of the genomic locations of its defining mutations and a lack of the rapid evolutionary rate on its ancestral branch. As new variants, such as Omicron, continue to evolve (potentially through similar mechanisms), it remains important to investigate the origins of other variants to identify ways to potentially disrupt their evolution and emergence. Oxford University Press 2022-08-26 /pmc/articles/PMC9752794/ /pubmed/36533153 http://dx.doi.org/10.1093/ve/veac080 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Research Article Hill, Verity Du Plessis, Louis Peacock, Thomas P Aggarwal, Dinesh Colquhoun, Rachel Carabelli, Alesandro M Ellaby, Nicholas Gallagher, Eileen Groves, Natalie Jackson, Ben McCrone, J T O’Toole, Áine Price, Anna Sanderson, Theo Scher, Emily Southgate, Joel Volz, Erik Barclay, Wendy S Barrett, Jeffrey C Chand, Meera Connor, Thomas Goodfellow, Ian Gupta, Ravindra K Harrison, Ewan M Loman, Nicholas Myers, Richard Robertson, David L Pybus, Oliver G Rambaut, Andrew The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK |
title | The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK |
title_full | The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK |
title_fullStr | The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK |
title_full_unstemmed | The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK |
title_short | The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK |
title_sort | origins and molecular evolution of sars-cov-2 lineage b.1.1.7 in the uk |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752794/ https://www.ncbi.nlm.nih.gov/pubmed/36533153 http://dx.doi.org/10.1093/ve/veac080 |
work_keys_str_mv | AT hillverity theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT duplessislouis theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT peacockthomasp theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT aggarwaldinesh theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT colquhounrachel theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT carabellialesandrom theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT ellabynicholas theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT gallaghereileen theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT grovesnatalie theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT jacksonben theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT mccronejt theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT otooleaine theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT priceanna theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT sandersontheo theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT scheremily theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT southgatejoel theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT volzerik theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT barclaywendys theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT barrettjeffreyc theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT chandmeera theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT connorthomas theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT goodfellowian theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT guptaravindrak theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT harrisonewanm theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT lomannicholas theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT myersrichard theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT robertsondavidl theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT pybusoliverg theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT rambautandrew theoriginsandmolecularevolutionofsarscov2lineageb117intheuk AT hillverity originsandmolecularevolutionofsarscov2lineageb117intheuk AT duplessislouis originsandmolecularevolutionofsarscov2lineageb117intheuk AT peacockthomasp originsandmolecularevolutionofsarscov2lineageb117intheuk AT aggarwaldinesh originsandmolecularevolutionofsarscov2lineageb117intheuk AT colquhounrachel originsandmolecularevolutionofsarscov2lineageb117intheuk AT carabellialesandrom originsandmolecularevolutionofsarscov2lineageb117intheuk AT ellabynicholas originsandmolecularevolutionofsarscov2lineageb117intheuk AT gallaghereileen originsandmolecularevolutionofsarscov2lineageb117intheuk AT grovesnatalie originsandmolecularevolutionofsarscov2lineageb117intheuk AT jacksonben originsandmolecularevolutionofsarscov2lineageb117intheuk AT mccronejt originsandmolecularevolutionofsarscov2lineageb117intheuk AT otooleaine originsandmolecularevolutionofsarscov2lineageb117intheuk AT priceanna originsandmolecularevolutionofsarscov2lineageb117intheuk AT sandersontheo originsandmolecularevolutionofsarscov2lineageb117intheuk AT scheremily originsandmolecularevolutionofsarscov2lineageb117intheuk AT southgatejoel originsandmolecularevolutionofsarscov2lineageb117intheuk AT volzerik originsandmolecularevolutionofsarscov2lineageb117intheuk AT barclaywendys originsandmolecularevolutionofsarscov2lineageb117intheuk AT barrettjeffreyc originsandmolecularevolutionofsarscov2lineageb117intheuk AT chandmeera originsandmolecularevolutionofsarscov2lineageb117intheuk AT connorthomas originsandmolecularevolutionofsarscov2lineageb117intheuk AT goodfellowian originsandmolecularevolutionofsarscov2lineageb117intheuk AT guptaravindrak originsandmolecularevolutionofsarscov2lineageb117intheuk AT harrisonewanm originsandmolecularevolutionofsarscov2lineageb117intheuk AT lomannicholas originsandmolecularevolutionofsarscov2lineageb117intheuk AT myersrichard originsandmolecularevolutionofsarscov2lineageb117intheuk AT robertsondavidl originsandmolecularevolutionofsarscov2lineageb117intheuk AT pybusoliverg originsandmolecularevolutionofsarscov2lineageb117intheuk AT rambautandrew originsandmolecularevolutionofsarscov2lineageb117intheuk |